Takeda Pharmaceutical (TAK) Earnings Analysis
Takeda Pharmaceutical (TAK) next reports earnings on 2026-07-30, consensus EPS 0.1689 USD. Last quarter (2026-01-29) it missed with EPS 0.48 USD vs 0.55 USD est (-12.7%). It has beaten estimates in 3/5 recent quarters (60%). Trailing P/E 45.13.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does TAK next report earnings?
| Next earnings date | 2026-07-30 |
|---|---|
| Consensus EPS estimate | 0.1689 USD |
| Revenue estimate | 7.15B |
TAK earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-01-29 | 0.48 USD | 0.55 USD | -12.7% | Miss |
| 2025-10-30 | 0.44 USD | 0.44 USD | 0% | Beat |
| 2025-07-30 | 0.52 USD | 0.47 USD | +10.6% | Beat |
| 2025-01-30 | 0.42 USD | 0.63 USD | -33.3% | Miss |
| 2024-10-31 | 0.44 USD | 0.39 USD | +12.8% | Beat |
Beat rate: 3/5 (60%) over reported quarters with consensus data.
TAK valuation and analyst view
| Trailing P/E | 45.13 |
|---|---|
| Trailing EPS | 61.36 USD |
| Price / book | 1.11 |
| Dividend yield | 3.63% |
| Market cap | 53.91B |
| Analyst consensus | Buy (5 buy / 1 hold / 0 sell) |
Related research pages
Frequently asked questions
When is Takeda Pharmaceutical (TAK)'s next earnings date?
Takeda Pharmaceutical is next scheduled to report on 2026-07-30, with a consensus EPS estimate of 0.1689 USD and revenue estimate of 7.15B.
Did TAK beat earnings last quarter?
In its 2026-01-29 report, TAK posted EPS of 0.48 USD versus a 0.55 USD estimate — a miss of 12.7%.
What is TAK's earnings track record?
Over the last 5 reported quarters with consensus data, TAK beat estimates 3 times (60%).
What is TAK's current P/E ratio and EPS?
TAK trades at a trailing P/E of 45.13 on trailing EPS of 61.36 USD.
What do analysts rate TAK?
Analyst consensus is "Buy" across 6 ratings (0 strong buy, 5 buy, 1 hold, 0 sell, 0 strong sell).